3′-O-(3-Chloropivaloyl)quercetin, α-glucosidase inhibitor with multi-targeted therapeutic potential in relation to diabetic complications

References

Alexiou, P., Pegklidou, K., Chatzopoulou, M., Nicolaou, I., & Demopoulos, V. J. (2009). Aldose reductase enzyme and its implication to major health problems of the 21st century. Current Medicinal Chemistry, 16, 734–752. DOI: 10.2174/092986709787458362.Search in Google Scholar PubMed

Amic, D., Davidovic-Amic, D., Beslo, D., Rastija, V., Lucic, B., & Trinajstic, N. (2007). SAR and QSAR of the antioxidant activity of flavonoids. Current Medicinal Chemistry, 14, 827– 845. DOI: 10.2174/092986707780090954.Search in Google Scholar PubMed

Blois, M. S. (1958). Antioxidant determinations by the use of a stable free radical. Nature, 181, 1199–1200. DOI: 10.1038/1811199a0.Search in Google Scholar

Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008). Health effects of quercetin: From antioxidant to nuhaceutical. European Journal of Pharmacology, 585, 325–337. DOI: 10.1016/j.ejphar.2008.03.008.Search in Google Scholar PubMed

Bors, W., & Michel, C. (2002). Chemistry of the antioxidant effect of polyphenols. Annals of the New York Academy of Sciences, 957, 57–69. DOI: 10.1111/j.1749-6632.2002.tb02905.x.Search in Google Scholar PubMed

Butković, V., Klasinc, L., & Bors, W. (2004). Kinetic study of flavonoid reactions with stable radicals. Journal of Agricultural and Food Chemistry, 52, 2816–2820. DOI: 10.1021/jf049880h.Search in Google Scholar PubMed

Cao, H., & Chen, X. Q. (2012). Structures required of flavonoids for inhibiting digestive enzymes. Anti-Cancer Agents in Medicinal Chemistry, 12, 929–939. DOI: 10.2174/187152012 802650110.Search in Google Scholar

Chatzopoulou, M., Alexiou, P., Kotsampasakou, E., & Demopoulos, V. J. (2012). Novel aldose reductase inhibitors: A patent survey (2006–present). Expert Opinion on Therapeutic Patents, 11, 1303–1323. DOI: 10.1517/13543776.2012.72 6615.Search in Google Scholar

Chatzopoulou, M., Pegklidou, K., Papastavrou, N., & Demopoulos, V. J. (2013). Development of aldose reductase inhibitors for the treatment of inflammatory disorders. Expert Opinion on Drug Discovery, 8, 1365–1380. DOI: 10.1517/17460441.2013.843524.Search in Google Scholar PubMed

Chen, J., Mangelinckx, S., Adams, A., Wang, Z. T., Li, W. L., & De Kimpe, N. (2015). Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Natural Product Communications, 10, 187–200.10.1177/1934578X1501000140Search in Google Scholar

Goupy, P., Dufour, C., Loonis, M., & Dangles, O. (2003). Quantitative kinetic analysis of hydrogen transfer reactions from dietary polyphenols to the DPPH radical. Journal of Agricultural and Food Chemistry, 51, 615–622. DOI: 10.1021/jf025938l.Search in Google Scholar

Hakamata, W., Kurihara, M., Okuda, H., Nishio, T., & Oku, T. (2009). Design and screening strategies for α-glucosidase inhibitors based on enzymological information. Current Topics in Medicinal Chemistry, 9, 3–12. DOI: 10.2174/156802609787354306.Search in Google Scholar

Hayman, S., & Kinoshita, J. H. (1965). Isolation and properties of lens aldose reductase. The Journal of Biological Chemistry, 240, 877–882.10.1016/S0021-9258(17)45256-2Search in Google Scholar

Kelsey, N. A., Wilkins, H. M., & Linseman, D. A. (2010). Nutraceutical antioxidants as novel neuroprotective agents. Molecules, 15, 7792–7814. DOI: 10.3390/molecules15117792.Search in Google Scholar PubMed PubMed Central

Kuniaková, M., Mrvová, N., Knezl, V., & Račková, Ľ. (2015). Effect of novel quercetin pivaloyl ester on functions of adult rat microglia. Biologia, 70, 690–702. DOI: 10.1515/biolog-2015-0082.Search in Google Scholar

Kwon, Y. I., Vattem, D. A., & Shetty, K. (2006). Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pacific Journal of Clinical Nutrition, 15, 107–118.Search in Google Scholar

Majumdar, S., & Srirangam, R. (2010). Potential of the bioflavonoids in the prevention/treatment of ocular disorders. Journal of Pharmacy and Pharmacology, 62, 951–965. DOI: 10.1211/jpp.62.08.0001.Search in Google Scholar PubMed PubMed Central

Matsuda, H., Morikawa, T., Toguchida, I., & Yoshikawa, M. (2002). Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chemical & Pharmaceutical Bulletin, 50, 788–795. DOI: 10.1248/cpb.50.788.Search in Google Scholar PubMed

Matsuda, H., Wang, T., Managi, H., & Yoshikawa, M. (2003). Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorganic & Medicinal Chemistry, 11, 5317–5323. DOI: 10.1016/j.bmc. 2003.09.045.Search in Google Scholar

Miyamoto, S. (2002). Recent advances in aldose reductase inhibitors: Potential agents for the treatment of diabetic complications. Expert Opinion on Therapeutic Patents, 12, 621– 631. DOI: 10.1517/13543776.12.5.621.Search in Google Scholar

Milackova, I., Kovacikova, L., Veverka, M., Gallovic, E., & Stefek, M. (2013). Screening for antiradical efficiency of 21 semi-synthetic derivatives of quercetin in a DPPH assay. Interdisciplinary Toxicology, 6, 13–17. DOI: 10.2478/intox-2013-0003.Search in Google Scholar PubMed PubMed Central

Milackova, I., Soltesova Prnova, M., Majekova, M., Sotnikova, R., Stasko, M., Kovacikova, L., Banerjee, S., Veverka, M., & Stefek, M. (2015). 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent. Journal of Enzyme Inhibition and Medicinal Chemistry, 30, 107–113. DOI: 10.3109/14756366. 2014.892935.Search in Google Scholar

Mrvová, N., Škandík, M., Kuniaková, M., & Račková, L. (2015). Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester. Neurochemistry International, 90, 246–254. DOI: 10.1016/j.neuint.2015.09.005.Search in Google Scholar

Mylari, B. L., Armento, S. J., Beebe, D. A., Conn, E. L., Coutcher, J. B., Dina, M. S., O’Gorman, M. T., Linhares, M. C., Martin, W. H., Oates, P. J., Tess, D. A., Withbroe, G. J., & Zembrowski, W. J. (2003). A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2-H-pyridazin-3-one. Journal of Medicinal Chemistry, 46, 2283–2286. DOI: 10.1021/ jm034065z.Search in Google Scholar

Nijveldt, R. J., van Nood, E., van Hoorn, D. E. C., Boelens, P. G., van Norren, K., & van Leeuwen, P. A. M. (2001). Flavonoids: A review of probable mechanisms of action and potential applications. American Journal of Clinical Nutrition, 74, 418–425.10.1093/ajcn/74.4.418Search in Google Scholar

Park, H. S., Hwang, K. Y., Oh, K. H., Kim, Y. H., Lee, J. Y., & Kim, K. (2008). Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure. Bioorganic & Medicinal Chemistry, 16, 284–292. DOI: 10.1016/j.bmc.2007.09.036.Search in Google Scholar

Ratty, A. K., Sunamoto, J., & Das, N. P. (1988). Interaction of flavonoids with 1,1-diphenyl-2-picrylhydrazyl free radical, liposomal membranes and soybean lipoxygenase-1. Biochemical Pharmacology, 37, 989–996. DOI: 10.1016/0006-2952(88)90499-6.Search in Google Scholar

Singh, R., Kaur, N., Kishore, L., & Gupta, G. K. (2013). Management of diabetic complications: A chemical constituents based approach. Journal of Ethnopharmacology, 150, 51–70. DOI: 10.1016/j.jep.2013.08.051.Search in Google Scholar PubMed

Srivastava, S. K., Ramana, K. V., & Bhatnagar, A. (2005). Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocrine Reviews, 26, 380–392. DOI: 10.1210/er.2004-0028.Search in Google Scholar PubMed

Stefek, M., Snirc, V., Djoubissie, P. O., Majekova, M., Demopoulos, V., Račková, Ľ., Bezakova, Z., Karasu, C., Carbone, V., & El-Kabbani, O. (2008). Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning and molecular modelling. Bioorganic & Medicinal Chemistry, 16, 4908–4920. DOI: 10.1016/j.bmc.2008.03.039.Search in Google Scholar PubMed

Stefek, M. (2011). Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdisciplinary Toxicology, 4, 69–77. DOI: 10.2478/v10102-011-0013-y.Search in Google Scholar PubMed PubMed Central

Stefek, M., Tsantili-Kakoulidou, A., Milackova, I., Juskova, M., Snirc, V., & Triantos, N. (2011). (2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-6]indol-8-yl)-acetic acid: An aldose reductase inhibitor and antioxidant of zwitterionic nature. Bioorganic & Medicinal Chemistry, 19, 7181–7185. DOI: 10.1016/j.bmc.2011.09.053.Search in Google Scholar PubMed

Veverka, M., Gallovič, J., Švajdlenka, E., Veverková, E., Prónayová, N., Miláčková, I., & Štefek, M. (2013). Novel quercetin derivatives: Synthesis and screening for antioxidant activity and aldose reductase inhibition. Chemical Papers, 67, 76–83. DOI: 10.2478/s11696-012-0240-5.Search in Google Scholar

Villaño, D., Fernández-Pachón, M. S., Moyá, M. L., Troncoso, A. M., & García-Parrilla, M. C. (2007). Radical scavenging ability of polyphenolic compounds towards DPPH free radical. Talanta, 71, 230–235. DOI: 10.1016/j.talanta.2006.03. 050.Search in Google Scholar

Williams, R. J., Spencer, J. P. E., & Rice-Evans, C. (2004). Flavonoids: Antioxidants or signalling molecules? Free Radical Biology & Medicine, 36, 838–849. DOI: 10.1016/j. freeradbiomed. 2004.01.001.Search in Google Scholar

Xiao, J. B., Kai, G. Y., Yamamoto, K., & Chen, X. Q. (2013). Advance in dietary polyphenols as α-glucosidases inhibitors: A review on structure–activity relationship aspect. Critical Reviews in Food Science and Nutrition, 53, 818–836. DOI: 10.1080/10408398.2011.561379.Search in Google Scholar PubMed

Yabe-Nishimura, C. (1998). Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacological Reviews, 1, 50, 21–33.Search in Google Scholar

Zižková, P., Blaškovič, D., Májeková, M., Švorc, L., Račková, L., Ratkovská, Ľ., Veverka, M., & Horáková, Ľ. (2014). Novel quercetin derivatives in treatment of peroxynitrite-oxidized SERCA1. Molecular and Cellular Biochemistry, 386, 1–14. DOI: 10.1007/s11010-013-1839-8.Search in Google Scholar PubMed